115
|
388
|
4wegA |
Influenza virus neuraminidase n9 in complex 2,3-difluorosialic acid |
186
|
679
|
4sliA |
Leech intramolecular trans-sialidase complexed with 2-propenyl-neu5ac, an inactive substrate analogue |
119
|
389
|
4qn4A |
Crystal structure of neuraminidase n6 |
124
|
390
|
4qn3A |
Crystal structure of neuraminidase n7 |
117
|
386
|
4qnpA |
Crystal structure of the 2009 pandemic h1n1 influenza virus neuraminidase with a neutralizing antibody |
117
|
389
|
4qn6A |
Crystal structure of neuraminidase n6 complexed with laninamivir |
98
|
408
|
4r40A |
Crystal structure of tolb/pal complex from yersinia pestis. |
119
|
390
|
4qn7A |
Crystal structure of neuramnidase n7 complexed with oseltamivir |
115
|
394
|
4qn5A |
Neuraminidase n5 binds lsta at the second sia binding site |
108
|
408
|
4pwzA |
Crystal structure of tolb protein from yersinia pestis co92 |
154
|
523
|
4q6kA |
Crystal structure of a putative neuraminidase (baccac_01090) from bacteroides caccae atcc 43185 at 1.90 a resolution (psi community target) |
79
|
338
|
4q1uA |
Serum paraoxonase-1 by directed evolution with the k192q mutation |
92
|
376
|
4ncsA |
Human sialidase 2 in complex with 2,3-difluorosialic acid (covalent intermediate) |
79
|
323
|
4o5sA |
Crystal structure of diels-alderase ce11 |
64
|
286
|
4n1bA |
Structure of keap1 kelch domain with(1s,2r)-2-[(1s)-1-[(1-oxo-2,3-dihydro-1h-isoindol-2-yl)methyl]-1,2,3,4-tetrahydroisoquinoline-2-carbonyl]cyclohexane-1-carboxylic acid |
96
|
376
|
4nc5A |
Human sialidase 2 in complex with 2,3-difluorosialic acid (covalent intermediate) |
114
|
388
|
4nn9A |
Refined atomic structures of n9 subtype influenza virus neuraminidase and escape mutants |
71
|
322
|
4o5tA |
Crystal structure of diels-alderase ce20 in complex with a product analog |
112
|
432
|
4mzeA |
Crystal structure of hpiv3 hemagglutinin-neuraminidase, h552q/q559r mutant |
117
|
388
|
4mwvA |
Anhui n9-peramivir |
120
|
388
|
4mwrA |
Anhui n9-zanamivir |
121
|
388
|
4mwuA |
Anhui n9-laninamivir |
121
|
388
|
4mx0A |
Shanghai n9-peramivir |
119
|
388
|
4mwyA |
Shanghai n9-laninamivir |
114
|
432
|
4mzaA |
Crystal structure of hpiv3 hemagglutinin-neuraminidase |
119
|
388
|
4mwxA |
Shanghai n9-zanamivir |
120
|
388
|
4mwwA |
Shanghai n9-oseltamivir carboxylate |
121
|
388
|
4mwjA |
Anhui n9 |
119
|
388
|
4mwqA |
Anhui n9-oseltamivir carboxylate |
108
|
384
|
4m4uA |
Structural evaluation d84a mutant of the aspergillus fumigatus kdnase (sialidase) |
113
|
389
|
4mjuA |
Influenza neuraminidase in complex with a novel antiviral compound |
111
|
385
|
4m4vA |
Structural evaluation r171l mutant of the aspergillus fumigatus kdnase (sialidase) |
117
|
388
|
4mwlA |
Shanghai n9 |
110
|
386
|
4m4nA |
Structural evaluation the y358h mutant of the aspergillus fumigatus kdnase (sialidase) |
82
|
363
|
4mc7A |
Crystal structure of a subtype n11 neuraminidase-like protein of a/flat-faced bat/peru/033/2010 (h18n11) |
109
|
390
|
4mjvA |
Influenza neuraminidase in complex with a novel antiviral compound |
119
|
390
|
4m3mA |
Influenza neuraminidase in complex with a stereomutated analogue of oseltamivir carboxylate |
62
|
286
|
4l7dA |
Structure of keap1 kelch domain with (1s,2r)-2-{[(1s)-5-methyl-1-[(1-oxo-1,3-dihydro-2h-isoindol-2-yl)methyl]-3,4-dihydroisoquinolin-2(1h)-yl]carbonyl}cyclohexanecarboxylic acid |
89
|
364
|
4k3yA |
Crystal structure of a subtype n11 neuraminidase-like protein of a/flat-faced bat/peru/033/2010 (h18n11) |
103
|
388
|
4ks5A |
Influenza neuraminidase in complex with antiviral compound (3s,4r,5r)-4-(acetylamino)-3-[4-(2-hydroxypropan-2-yl)-1h-1,2,3-triazol-1-yl]-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid |
61
|
291
|
4l7bA |
Structure of keap1 kelch domain with (1s,2r)-2-{[(1s)-1-[(1,3-dioxo-1,3-dihydro-2h-isoindol-2-yl)methyl]-3,4-dihydroisoquinolin-2(1h)-yl]carbonyl}cyclohexanecarboxylic acid |
115
|
389
|
4ks4A |
Influenza neuraminidase in complex with antiviral compound (3s,4r,5r)-4-(acetylamino)-3-{4-[(1r)-1-hydroxypropyl]-1h-1,2,3-triazol-1-yl}-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid |
107
|
389
|
4ks2A |
Influenza neuraminidase in complex with antiviral compound (3s,4r,5r)-4-(acetylamino)-3-carbamimidamido-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid |
118
|
388
|
4k1iA |
Induced opening of influenza virus neuraminidase n2 150-loop suggests an important role in inhibitor binding |
118
|
389
|
4ks1A |
Influenza neuraminidase in complex with antiviral compound (3s,4r,5r)-4-(acetylamino)-3-amino-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid |
115
|
388
|
4k1kA |
Induced opening of influenza virus neuraminidase n2 150-loop suggests an important role in inhibitor binding |
105
|
388
|
4ks3A |
Influenza neuraminidase in complex with antiviral compound (3s,4r,5r)-4-(acetylamino)-3-[4-(3-hydroxypropyl)-1h-1,2,3-triazol-1-yl]-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid |
118
|
388
|
4k1hA |
Induced opening of influenza virus neuraminidase n2 150-loop suggests an important role in inhibitor binding |
107
|
388
|
4k1jA |
Induced opening of influenza virus neuraminidase n2 150-loop suggests an important role in inhibitor binding |
63
|
286
|
4l7cA |
Structure of keap1 kelch domain with 2-{[(1s)-2-{[(1r,2s)-2-(1h-tetrazol-5-yl)cyclohexyl]carbonyl}-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-1h-isoindole-1,3(2h)-dione |